Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 849.59 Million CNY | 21.11% |
| 2022 | 701.51 Million CNY | 24.42% |
| 2021 | 563.81 Million CNY | -20.78% |
| 2020 | 711.71 Million CNY | 3.84% |
| 2019 | 685.42 Million CNY | 29.77% |
| 2018 | 528.18 Million CNY | 31.59% |
| 2017 | 401.37 Million CNY | 25.04% |
| 2016 | 321.01 Million CNY | 54.05% |
| 2015 | 208.37 Million CNY | 22.72% |
| 2014 | 169.79 Million CNY | 13.64% |
| 2013 | 149.41 Million CNY | 43.18% |
| 2012 | 104.35 Million CNY | 24.93% |
| 2011 | 83.52 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 163.84 Million CNY | -45.45% |
| 2024 Q3 | 251.71 Million CNY | 53.63% |
| 2024 Q1 | 300.34 Million CNY | 71.62% |
| 2023 Q3 | 231.6 Million CNY | 27.32% |
| 2023 Q1 | 261.07 Million CNY | 106.81% |
| 2023 Q2 | 181.9 Million CNY | -30.32% |
| 2023 Q4 | 175.01 Million CNY | -24.44% |
| 2023 FY | 849.59 Million CNY | 21.11% |
| 2022 Q3 | 206.19 Million CNY | 39.19% |
| 2022 Q1 | 220.94 Million CNY | 136.33% |
| 2022 FY | 701.51 Million CNY | 24.42% |
| 2022 Q4 | 126.23 Million CNY | -38.78% |
| 2022 Q2 | 148.13 Million CNY | -32.95% |
| 2021 Q3 | 168.98 Million CNY | 38.89% |
| 2021 Q1 | 207.75 Million CNY | 101.24% |
| 2021 FY | 563.81 Million CNY | -20.78% |
| 2021 Q2 | 121.66 Million CNY | -41.44% |
| 2021 Q4 | 93.49 Million CNY | -44.68% |
| 2020 Q3 | 213.6 Million CNY | 1.78% |
| 2020 Q4 | 103.23 Million CNY | -51.67% |
| 2020 FY | 711.71 Million CNY | 3.84% |
| 2020 Q1 | 185 Million CNY | 34.16% |
| 2020 Q2 | 209.86 Million CNY | 13.44% |
| 2019 Q3 | 191.36 Million CNY | -2.21% |
| 2019 Q2 | 195.7 Million CNY | 21.97% |
| 2019 Q1 | 160.45 Million CNY | 16.8% |
| 2019 FY | 685.42 Million CNY | 29.77% |
| 2019 Q4 | 137.9 Million CNY | -27.94% |
| 2018 Q4 | 137.37 Million CNY | 1.59% |
| 2018 Q3 | 135.22 Million CNY | -4.99% |
| 2018 FY | 528.18 Million CNY | 31.59% |
| 2018 Q2 | 142.32 Million CNY | 25.67% |
| 2018 Q1 | 113.25 Million CNY | 1.33% |
| 2017 Q2 | 108.08 Million CNY | 29.1% |
| 2017 Q4 | 111.76 Million CNY | 14.27% |
| 2017 FY | 401.37 Million CNY | 25.04% |
| 2017 Q1 | 83.72 Million CNY | -8.22% |
| 2017 Q3 | 97.8 Million CNY | -9.51% |
| 2016 Q3 | 82.41 Million CNY | -1.27% |
| 2016 FY | 321.01 Million CNY | 54.05% |
| 2016 Q4 | 91.22 Million CNY | 10.68% |
| 2016 Q2 | 83.47 Million CNY | 30.64% |
| 2016 Q1 | 63.89 Million CNY | 26.84% |
| 2015 Q3 | 57.41 Million CNY | -3.18% |
| 2015 FY | 208.37 Million CNY | 22.72% |
| 2015 Q1 | 41.28 Million CNY | -5.05% |
| 2015 Q2 | 59.3 Million CNY | 43.63% |
| 2015 Q4 | 50.37 Million CNY | -12.26% |
| 2014 Q3 | 39.73 Million CNY | -17.74% |
| 2014 Q4 | 43.48 Million CNY | 9.44% |
| 2014 FY | 169.79 Million CNY | 13.64% |
| 2014 Q2 | 48.3 Million CNY | 26.19% |
| 2014 Q1 | 38.27 Million CNY | 3.19% |
| 2013 Q3 | 51.74 Million CNY | 0.0% |
| 2013 FY | 149.41 Million CNY | 43.18% |
| 2013 Q4 | 37.09 Million CNY | -28.32% |
| 2012 FY | 104.35 Million CNY | 24.93% |
| 2011 FY | 83.52 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 1.04 Billion CNY | 18.935% |
| Liaoning Cheng Da Co., Ltd. | 233.08 Million CNY | -264.502% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 3.76 Billion CNY | 77.452% |